Broad Spectrum Antiviral Compounds Targeting SKI Complex
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for broad-spectrum antiviral compounds that can effectively treat various viruses, including emerging coronaviruses and other pathogens, as demonstrated by the SARS-CoV-2 pandemic, highlighting the inadequacy of current specific antiviral therapies.
Innovation Solution
Development of specific compounds, such as those represented by formulas (I), (II), (III), (IV), (V), and their derivatives, which inhibit SKI complex activity, inhibit viral replication, and induce interferon signaling, thereby providing a therapeutic approach for viral infections and potentially other conditions like cancer.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If specific antiviral therapies are used, then efficacy against a particular virus is improved, but broad-spectrum coverage against emerging viruses deteriorates
Solution Approach 1:
The patent develops compounds that target the SKI complex, a host cellular machinery used by multiple different viruses (influenza, coronaviruses including SARS-CoV-2, RSV, and others) for replication. By inhibiting this universal host factor rather than virus-specific targets, a single compound can provide broad-spectrum antiviral activity across multiple virus families, resolving the contradiction between specific efficacy and broad coverage
Solution Approach 2:
The invention uses the SKI complex as an intermediary target - instead of directly targeting each virus, the compounds interfere with the host cellular pathway (SKI complex) that mediates viral replication. This intermediary approach allows one compound to affect multiple viruses that all depend on this common host pathway, achieving both reliability and versatility
2Adaptability or versatility
If broad-spectrum antiviral compounds are developed, then coverage against multiple viruses is improved, but specificity and targeted efficacy deteriorate
Solution Approach 1:
The compounds are designed to target a universal host factor (SKI complex) that is essential for replication across multiple virus types. This universality ensures that the same compound mechanism can effectively address diverse viruses while maintaining reliable antiviral efficacy through consistent inhibition of the shared replication pathway
3Adaptability or versatility
If host-targeted therapy is used, then broad-spectrum antiviral activity is improved, but off-target effects and toxicity worsen
Solution Approach 1:
The patent employs computational modeling and virtual screening to identify compounds that specifically bind to the SKI complex binding pocket. By using in silico methods to predict and optimize binding interactions before synthesis and testing, the approach enables precise targeting of the intended host factor while minimizing off-target effects, thus expanding antiviral spectrum without proportionally increasing toxicity
Data Source
AI summary
Compounds and methods of using the same for treating conditions alleviated by SKI complex inhibition, viral replication inhibition, or interferon signaling inducement are provided.